EP Patent

EP1917971A1 — Substained release formulations comprising very low molecular weight polymers

Assigned to Ipsen Pharma SAS · Expires 2008-05-07 · 18y expired

What this patent protects

The present invention relates to a parenteral sustained-release semi-solid formulation comprising an oligomer end-capped and an active substance without any supplementary viscosity reducing agent or excipient.

USPTO Abstract

The present invention relates to a parenteral sustained-release semi-solid formulation comprising an oligomer end-capped and an active substance without any supplementary viscosity reducing agent or excipient.

Drugs covered by this patent

Patent Metadata

Patent number
EP1917971A1
Jurisdiction
EP
Classification
—
Expires
2008-05-07
Drug substance claim
No
Drug product claim
No
Assignee
Ipsen Pharma SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.